Shineco subsidiary signs $8.7M tech services contract

September 12, 2025 9:30 AM EDT

Shineco Inc. (NASDAQ: SISI) announced that its subsidiary Xi'an Dong'ao Health Management Co., Ltd. signed a technology services contract valued at $8.7 million with Xinke Future Biotechnology (Bazhou) Co., Ltd. for research and development of microalgae-derived extracellular vesicles technology.

The contract runs from August 25, 2025, to December 31, 2026. The company received an initial payment of $560,000, with subsequent payments tied to research and development milestones. The project aims to build a research and development system from basic research to product development, including functional validation and large-scale production processes.

Separately, a delegation from Singapore biotechnology company BICC visited Dong'ao Health from September 6-10. The parties agreed to establish a joint laboratory and implement a technology exchange mechanism. BICC operates a network of over 3,000 agents across Southeast Asia.

The delegation inspected Dong'ao Health's facilities, including its Health and Wellness Center, Cell R&D Center, an under-construction Alzheimer's Disease Care Town, and partner medical aesthetic hospital. The companies plan to integrate BICC's Southeast Asian distribution network with Dong'ao Health's domestic wellness channels and co-establish stem cell transfusion centers.

"This contract is a powerful validation of our strategy to monetize cutting-edge research and create near-term revenue," said Jennifer Zhan, CEO of Shineco. "Coupled with our strategic alliance with BICC, it provides two clear, synergistic engines for growth."

Shineco develops and commercializes induced pluripotent stem cell technology platforms. The company stated it will provide regular updates on contract execution and the BICC collaboration in accordance with NASDAQ disclosure rules.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News

Related Entities

Maynard Um, Mark Zuckerberg, ARK